Journal of Clinical Oncology, ISSN 0732-183X, 08/2012, Volume 30, Issue 24, pp. 2995 - 3001
Purpose Reported survival in patients with myeloproliferative neoplasms (MPNs) shows great variation. Patients with primary myelofibrosis (PMF) have...
POLYCYTHEMIA-VERA | PROGNOSTIC-FACTORS | ONCOLOGY | TYROSINE KINASE JAK2 | OLMSTED COUNTY | ESSENTIAL THROMBOCYTHEMIA | PRIMARY MYELOFIBROSIS | CONSECUTIVE PATIENTS | LIFE EXPECTANCY | MYELOID METAPLASIA | INTERNATIONAL WORKING GROUP | Survival Rate - trends | Humans | Middle Aged | Aged, 80 and over | Female | Male | Registries | Aged | Sweden - epidemiology | Population Surveillance | Myeloproliferative Disorders - mortality | Hema3 | Original Reports
POLYCYTHEMIA-VERA | PROGNOSTIC-FACTORS | ONCOLOGY | TYROSINE KINASE JAK2 | OLMSTED COUNTY | ESSENTIAL THROMBOCYTHEMIA | PRIMARY MYELOFIBROSIS | CONSECUTIVE PATIENTS | LIFE EXPECTANCY | MYELOID METAPLASIA | INTERNATIONAL WORKING GROUP | Survival Rate - trends | Humans | Middle Aged | Aged, 80 and over | Female | Male | Registries | Aged | Sweden - epidemiology | Population Surveillance | Myeloproliferative Disorders - mortality | Hema3 | Original Reports
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 24, pp. 2851 - 2857
Purpose A dramatic improvement in the survival of patients with chronic myeloid leukemia (CML) occurred after the introduction of imatinib mesylate, the first...
CHRONIC MYELOGENOUS LEUKEMIA | TYROSINE KINASE INHIBITORS | SURVIVAL | TRIAL | INTERFERON-ALPHA | MODELS | ONCOLOGY | PHILADELPHIA-CHROMOSOME | 2ND | IMATINIB THERAPY | Protein Kinase Inhibitors - administration & dosage | Age Factors | Life Expectancy | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy | Sweden - epidemiology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Transplantation, Homologous | Stem Cell Transplantation - statistics & numerical data | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Klinisk medicin | Medicin och hälsovetenskap
CHRONIC MYELOGENOUS LEUKEMIA | TYROSINE KINASE INHIBITORS | SURVIVAL | TRIAL | INTERFERON-ALPHA | MODELS | ONCOLOGY | PHILADELPHIA-CHROMOSOME | 2ND | IMATINIB THERAPY | Protein Kinase Inhibitors - administration & dosage | Age Factors | Life Expectancy | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy | Sweden - epidemiology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Transplantation, Homologous | Stem Cell Transplantation - statistics & numerical data | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Cancer, ISSN 0008-543X, 06/2015, Volume 121, Issue 12, pp. 2072 - 2077
BACKGROUND The purpose of this study was to assess patterns of cancer occurrence during pregnancy and the postpartum period. METHODS This was a register‐based...
Sweden | cancer | population‐based | pregnancy | cancer register | population-based | BREAST-CANCER | WOMEN | ONCOLOGY | PROGNOSIS | Pregnancy | Young Adult | Humans | Adolescent | Adult | Female | Registries | Postpartum Period | Pregnancy Complications, Neoplastic - epidemiology | Sweden - epidemiology | Research Design | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Sweden | cancer | population‐based | pregnancy | cancer register | population-based | BREAST-CANCER | WOMEN | ONCOLOGY | PROGNOSIS | Pregnancy | Young Adult | Humans | Adolescent | Adult | Female | Registries | Postpartum Period | Pregnancy Complications, Neoplastic - epidemiology | Sweden - epidemiology | Research Design | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 11/2017, Volume 186, Issue 9, pp. 1065 - 1073
Previous studies have linked reductions in mammographic density after a breast cancer diagnosis to an improved prognosis. These studies focused on short-term...
mammographic density | breast cancer | joint model | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ERROR | TO-EVENT DATA | Body Mass Index | Prognosis | Antineoplastic Agents, Hormonal - pharmacology | Breast Density - drug effects | Humans | Middle Aged | Proportional Hazards Models | Mammography | Sweden - epidemiology | Breast Neoplasms - drug therapy | Breast Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Survival Analysis | Tamoxifen - pharmacology | Female | Aged | Breast Neoplasms - diagnostic imaging | Chemotherapy, Adjuvant | Longitudinal Studies | Breast Neoplasms - epidemiology | Prevention | Treatment outcome | Usage | Hormone therapy | Patient outcomes | Postmenopausal women | Breast cancer | Dosage and administration | Diagnosis | Tamoxifen | Comparative analysis | Health aspects | Original Contributions
mammographic density | breast cancer | joint model | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ERROR | TO-EVENT DATA | Body Mass Index | Prognosis | Antineoplastic Agents, Hormonal - pharmacology | Breast Density - drug effects | Humans | Middle Aged | Proportional Hazards Models | Mammography | Sweden - epidemiology | Breast Neoplasms - drug therapy | Breast Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Survival Analysis | Tamoxifen - pharmacology | Female | Aged | Breast Neoplasms - diagnostic imaging | Chemotherapy, Adjuvant | Longitudinal Studies | Breast Neoplasms - epidemiology | Prevention | Treatment outcome | Usage | Hormone therapy | Patient outcomes | Postmenopausal women | Breast cancer | Dosage and administration | Diagnosis | Tamoxifen | Comparative analysis | Health aspects | Original Contributions
Journal Article
BMC Medical Research Methodology, ISSN 1471-2288, 2011, Volume 11, Issue 1, pp. 96 - 96
Background: When the mortality among a cancer patient group returns to the same level as in the general population, that is, the patients no longer experience...
PROPORTIONAL-HAZARDS | FRACTION | COLON | TRENDS | HEALTH CARE SCIENCES & SERVICES | REGISTRY | Neoplasms - therapy | Algorithms | Life Expectancy | Humans | Proportional Hazards Models | Survival Analysis | Treatment Outcome | Models, Statistical | Care and treatment | Colon cancer | Diagnosis | Research
PROPORTIONAL-HAZARDS | FRACTION | COLON | TRENDS | HEALTH CARE SCIENCES & SERVICES | REGISTRY | Neoplasms - therapy | Algorithms | Life Expectancy | Humans | Proportional Hazards Models | Survival Analysis | Treatment Outcome | Models, Statistical | Care and treatment | Colon cancer | Diagnosis | Research
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2013, Volume 162, Issue 4, pp. 509 - 516
Summary The 5‐year relative survival of adults diagnosed with acute myeloid leukaemia (AML) was less than 10% during the 1970s and 1980s in England. This...
England | cure | acute myeloid leukaemia | outcome | survival | Acute myeloid leukaemia | Cure | Survival | Outcome | SWEDEN | DIAGNOSIS | CANCER-REGISTRY DATA | ADULTS | INDUCTION | TRIAL | RECOMMENDATIONS | TEMPORAL TRENDS | HEMATOLOGY | PATIENT SURVIVAL | Humans | Middle Aged | Male | Survival Rate | Treatment Outcome | Mortality - trends | Remission Induction | Leukemia, Myeloid, Acute - mortality | Young Adult | Registries - statistics & numerical data | England - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Leukemia, Myeloid, Acute - therapy
England | cure | acute myeloid leukaemia | outcome | survival | Acute myeloid leukaemia | Cure | Survival | Outcome | SWEDEN | DIAGNOSIS | CANCER-REGISTRY DATA | ADULTS | INDUCTION | TRIAL | RECOMMENDATIONS | TEMPORAL TRENDS | HEMATOLOGY | PATIENT SURVIVAL | Humans | Middle Aged | Male | Survival Rate | Treatment Outcome | Mortality - trends | Remission Induction | Leukemia, Myeloid, Acute - mortality | Young Adult | Registries - statistics & numerical data | England - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Leukemia, Myeloid, Acute - therapy
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2018, Volume 142, Issue 7, pp. 1343 - 1354
There is evidence of poor prognosis in women with pregnancy‐associated breast cancer (PABC) diagnosed during pregnancy or within 2 years of delivery. Using a...
breast cancer | TNM stage | hormone receptors | pregnancy | survival | DIAGNOSIS | STAGE | TIME | LAST PREGNANCY | ONCOLOGY | CHILDBIRTH | REPRODUCTIVE FACTORS | HORMONE-RECEPTOR | YOUNG-WOMEN | PATHOLOGICAL FEATURES | Prognosis | Humans | Pregnancy Complications, Neoplastic - mortality | Proportional Hazards Models | Pregnancy Complications, Neoplastic - pathology | Pregnancy | Young Adult | Sweden | Breast Neoplasms - pathology | Adolescent | Adult | Breast Neoplasms - mortality | Female | Cohort Studies | Breast cancer | Metastasis | Pregnant women | Mortality | Invasiveness | ErbB-2 protein | Metastases | Womens health | Quality | Medical prognosis | Health hazards | Breast | Diagnosis | Health risk assessment | Tumors | Cancer | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Survival | Hormone receptors | Clinical Medicine | Obstetrics, Gynecology and Reproductive Medicine | Reproduktionsmedicin och gynekologi | Cancer and Oncology | Cancer och onkologi
breast cancer | TNM stage | hormone receptors | pregnancy | survival | DIAGNOSIS | STAGE | TIME | LAST PREGNANCY | ONCOLOGY | CHILDBIRTH | REPRODUCTIVE FACTORS | HORMONE-RECEPTOR | YOUNG-WOMEN | PATHOLOGICAL FEATURES | Prognosis | Humans | Pregnancy Complications, Neoplastic - mortality | Proportional Hazards Models | Pregnancy Complications, Neoplastic - pathology | Pregnancy | Young Adult | Sweden | Breast Neoplasms - pathology | Adolescent | Adult | Breast Neoplasms - mortality | Female | Cohort Studies | Breast cancer | Metastasis | Pregnant women | Mortality | Invasiveness | ErbB-2 protein | Metastases | Womens health | Quality | Medical prognosis | Health hazards | Breast | Diagnosis | Health risk assessment | Tumors | Cancer | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Survival | Hormone receptors | Clinical Medicine | Obstetrics, Gynecology and Reproductive Medicine | Reproduktionsmedicin och gynekologi | Cancer and Oncology | Cancer och onkologi
Journal Article
Ambio, ISSN 0044-7447, 1/2015, Volume 44, Issue S3, pp. S392 - S401
Due to high terrestrial runoff, the Baltic Sea is rich in dissolved organic carbon (DOC), the light-absorbing fraction of which is referred to as colored...
Environment, general | CDOM | Secchi depth | Ecosystem | Physical Geography | Environmental Engineering/Biotechnology | Environment | DOC | Ecology | Atmospheric Sciences | Baltic Sea | Environmental Management | ZONE | OPTICAL-PROPERTIES | CLIMATE-CHANGE | WATERS | CDOM ABSORPTION | ENVIRONMENTAL SCIENCES | MODELS | ENGINEERING, ENVIRONMENTAL | TERRESTRIAL INPUTS | LAND-USE | ATLANTIC BIGHT | ECOSYSTEMS | Water Pollutants, Chemical | Environmental Monitoring | Carbon - analysis | Climate Change | Eutrophication | Environmental aspects | Runoff | Carbon | Organic compounds | Climate change | Biogeochemistry | Coastal zone management | Biological Sciences | Naturvetenskap | Biologiska vetenskaper | marin ekologi | Natural Sciences | Marine Ecology
Environment, general | CDOM | Secchi depth | Ecosystem | Physical Geography | Environmental Engineering/Biotechnology | Environment | DOC | Ecology | Atmospheric Sciences | Baltic Sea | Environmental Management | ZONE | OPTICAL-PROPERTIES | CLIMATE-CHANGE | WATERS | CDOM ABSORPTION | ENVIRONMENTAL SCIENCES | MODELS | ENGINEERING, ENVIRONMENTAL | TERRESTRIAL INPUTS | LAND-USE | ATLANTIC BIGHT | ECOSYSTEMS | Water Pollutants, Chemical | Environmental Monitoring | Carbon - analysis | Climate Change | Eutrophication | Environmental aspects | Runoff | Carbon | Organic compounds | Climate change | Biogeochemistry | Coastal zone management | Biological Sciences | Naturvetenskap | Biologiska vetenskaper | marin ekologi | Natural Sciences | Marine Ecology
Journal Article
BMC MEDICAL RESEARCH METHODOLOGY, ISSN 1471-2288, 07/2019, Volume 19, Issue 1, pp. 145 - 11
BackgroundThe life expectancy of cancer patients, and the loss in expectation of life as compared to the life expectancy without cancer, is a useful measure of...
POPULATION | COST | Life expectancy | Relative survival | HEALTH CARE SCIENCES & SERVICES | Loss in life expectancy | FLEXIBLE PARAMETRIC MODELS | FOLLOW-UP | Survival | BURDEN | Cancer
POPULATION | COST | Life expectancy | Relative survival | HEALTH CARE SCIENCES & SERVICES | Loss in life expectancy | FLEXIBLE PARAMETRIC MODELS | FOLLOW-UP | Survival | BURDEN | Cancer
Journal Article
Statistics in Medicine, ISSN 0277-6715, 03/2016, Volume 35, Issue 7, pp. 1193 - 1209
A now common goal in medical research is to investigate the inter‐relationships between a repeatedly measured biomarker, measured with error, and the time to...
joint modelling | mixed effects | adaptive Gauss–Hermite quadrature | delayed entry | survival analysis | left truncation | Left truncation | Survival analysis | Mixed effects | Joint modelling | Delayed entry | Adaptive Gauss-Hermite quadrature | MORTALITY | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICAL INFORMATICS | STATISTICS & PROBABILITY | DENSITY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PACKAGE | MATHEMATICAL & COMPUTATIONAL BIOLOGY | TIME-TO-EVENT | OUTCOMES | adaptive Gauss-Hermite quadrature | Biostatistics | Likelihood Functions | Computer Simulation | Humans | Proportional Hazards Models | Survival Analysis | Breast Neoplasms - mortality | Female | Breast Density | Models, Statistical | Longitudinal Studies | Special Issue Papers | Special Issue Paper
joint modelling | mixed effects | adaptive Gauss–Hermite quadrature | delayed entry | survival analysis | left truncation | Left truncation | Survival analysis | Mixed effects | Joint modelling | Delayed entry | Adaptive Gauss-Hermite quadrature | MORTALITY | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICAL INFORMATICS | STATISTICS & PROBABILITY | DENSITY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PACKAGE | MATHEMATICAL & COMPUTATIONAL BIOLOGY | TIME-TO-EVENT | OUTCOMES | adaptive Gauss-Hermite quadrature | Biostatistics | Likelihood Functions | Computer Simulation | Humans | Proportional Hazards Models | Survival Analysis | Breast Neoplasms - mortality | Female | Breast Density | Models, Statistical | Longitudinal Studies | Special Issue Papers | Special Issue Paper
Journal Article
BMC Medical Research Methodology, ISSN 1471-2288, 01/2019, Volume 19, Issue 1, pp. 23 - 13
BackgroundWithin cancer care, dynamic evaluations of the loss in expectation of life provides useful information to patients as well as physicians. The loss of...
Extrapolation | Loss of lifetime | Relative survival | Cancer survival | PROPORTIONAL-HAZARDS | TRIALS | EXPECTATION | HEALTH CARE SCIENCES & SERVICES | EXTRAPOLATING SURVIVAL | TIME | Analysis | Censorship | Lymphomas | Studies | Survival analysis | Accuracy | Mortality | Clinical trials | Cardiovascular disease | Cancer
Extrapolation | Loss of lifetime | Relative survival | Cancer survival | PROPORTIONAL-HAZARDS | TRIALS | EXPECTATION | HEALTH CARE SCIENCES & SERVICES | EXTRAPOLATING SURVIVAL | TIME | Analysis | Censorship | Lymphomas | Studies | Survival analysis | Accuracy | Mortality | Clinical trials | Cardiovascular disease | Cancer
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2017, Volume 140, Issue 1, pp. 34 - 40
Interval breast cancer (IC) has a more aggressive phenotype and higher mortality than screen‐detected cancer (SDC). In this case‐case study, we investigated...
cancer screening | mammography | mammographic density | breast cancer | longitudinal study | interval cancer | early detection | RISK PREDICTION | ONCOLOGY | PROGRAM | TUMOR CHARACTERISTICS | Body Mass Index | Early Detection of Cancer | Humans | Middle Aged | Logistic Models | Breast Neoplasms - drug therapy | Hormone Replacement Therapy | Breast Neoplasms - pathology | Postmenopause | Female | Aged | Breast Density | Breast Neoplasms - diagnostic imaging | Mammography - methods | Odds Ratio | Breasts | Population | Mammography | Hormone replacement therapy | Breast cancer | Health risk assessment | Tumors
cancer screening | mammography | mammographic density | breast cancer | longitudinal study | interval cancer | early detection | RISK PREDICTION | ONCOLOGY | PROGRAM | TUMOR CHARACTERISTICS | Body Mass Index | Early Detection of Cancer | Humans | Middle Aged | Logistic Models | Breast Neoplasms - drug therapy | Hormone Replacement Therapy | Breast Neoplasms - pathology | Postmenopause | Female | Aged | Breast Density | Breast Neoplasms - diagnostic imaging | Mammography - methods | Odds Ratio | Breasts | Population | Mammography | Hormone replacement therapy | Breast cancer | Health risk assessment | Tumors
Journal Article
BMC Medical Research Methodology, ISSN 1471-2288, 2012, Volume 12, Issue 1, pp. 86 - 86
Background: Relative survival is commonly used for studying survival of cancer patients as it captures both the direct and indirect contribution of a cancer...
Survival analysis | Regression models | Competing risks | Relative survival | Cancer | PROPORTIONAL-HAZARDS | DESIGN | CARDIAC TOXICITY | REGRESSION-MODELS | BREAST-CANCER | DISEASE | HEALTH CARE SCIENCES & SERVICES | COHORT | RADIOTHERAPY | Models, Theoretical | Prognosis | Humans | Middle Aged | Proportional Hazards Models | Risk | Models, Statistical | Cause of Death | Regression Analysis | Sweden | Survival Analysis | Cardiovascular Diseases - mortality | Breast Neoplasms - mortality | Female | Aged | Usage | Cancer patients | Oncology, Experimental | Analysis | Patient outcomes | Mortality | Survival after airplane accidents, shipwrecks, etc | Research | Epidemiology | Health sciences | Heart attacks | Disease | Calendars | Breast cancer | Radiation therapy | Cancer therapies | Studies | Womens health | Age
Survival analysis | Regression models | Competing risks | Relative survival | Cancer | PROPORTIONAL-HAZARDS | DESIGN | CARDIAC TOXICITY | REGRESSION-MODELS | BREAST-CANCER | DISEASE | HEALTH CARE SCIENCES & SERVICES | COHORT | RADIOTHERAPY | Models, Theoretical | Prognosis | Humans | Middle Aged | Proportional Hazards Models | Risk | Models, Statistical | Cause of Death | Regression Analysis | Sweden | Survival Analysis | Cardiovascular Diseases - mortality | Breast Neoplasms - mortality | Female | Aged | Usage | Cancer patients | Oncology, Experimental | Analysis | Patient outcomes | Mortality | Survival after airplane accidents, shipwrecks, etc | Research | Epidemiology | Health sciences | Heart attacks | Disease | Calendars | Breast cancer | Radiation therapy | Cancer therapies | Studies | Womens health | Age
Journal Article
British Journal of Cancer, ISSN 0007-0920, 2017, Volume 117, Issue 9, pp. 1419 - 1426
Background: Differences in cancer survival exist across socio-economic groups for many cancer types. Standard metrics fail to show the overall impact for...
UP-TO-DATE | POPULATION | INEQUALITIES | proportion of life lost | PERIOD ANALYSIS | life expectancy | total number of years lost | BREAST-CANCER | COLON-CANCER | MODELS | ONCOLOGY | WALES | PATIENT SURVIVAL | socio-economic differences | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasms - mortality | Male | Survival Rate | Neoplasms - diagnosis | Socioeconomic Factors | Life Expectancy | Registries - statistics & numerical data | Aged, 80 and over | Female | Aged | Neoplasm Staging | Stomach | Deprivation | Life expectancy | Lung cancer | Melanoma | Bladder | Breast cancer | Males | Medical diagnosis | Patients | Socioeconomics | Impact analysis | Life span | Urinary bladder | Rectum | Breast | Colon | Diagnosis | Females | Prostate | Cancer | Epidemiology
UP-TO-DATE | POPULATION | INEQUALITIES | proportion of life lost | PERIOD ANALYSIS | life expectancy | total number of years lost | BREAST-CANCER | COLON-CANCER | MODELS | ONCOLOGY | WALES | PATIENT SURVIVAL | socio-economic differences | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasms - mortality | Male | Survival Rate | Neoplasms - diagnosis | Socioeconomic Factors | Life Expectancy | Registries - statistics & numerical data | Aged, 80 and over | Female | Aged | Neoplasm Staging | Stomach | Deprivation | Life expectancy | Lung cancer | Melanoma | Bladder | Breast cancer | Males | Medical diagnosis | Patients | Socioeconomics | Impact analysis | Life span | Urinary bladder | Rectum | Breast | Colon | Diagnosis | Females | Prostate | Cancer | Epidemiology
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 79, pp. 106 - 118
Abstract Background Several types of cancers are causally linked to overweight and obesity, which are increasing in the Nordic countries. The aim of this study...
Hematology, Oncology and Palliative Medicine | Prevention | Obesity | Potential impact fraction | Population attributable fraction | Overweight | Cancer | EXCESS | RISK | ENVIRONMENTAL-FACTORS | BREAST-CANCER | INTERVENTIONS | LIFE-STYLE | ONCOLOGY | BODY-MASS INDEX | POOLED ANALYSIS | Prevalence | Humans | Middle Aged | Risk Factors | Male | Neoplasms - prevention & control | Incidence | Young Adult | Overweight - epidemiology | Obesity - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Neoplasms - epidemiology | Scandinavian and Nordic Countries - epidemiology | Epidemiology | Biometry | Analysis | VDP | Klinisk medisinske fag: 750 | Onkologi: 762 | Oncology: 762 | Medisinske Fag: 700 | Clinical medical disciplines: 750 | Medical disciplines: 700
Hematology, Oncology and Palliative Medicine | Prevention | Obesity | Potential impact fraction | Population attributable fraction | Overweight | Cancer | EXCESS | RISK | ENVIRONMENTAL-FACTORS | BREAST-CANCER | INTERVENTIONS | LIFE-STYLE | ONCOLOGY | BODY-MASS INDEX | POOLED ANALYSIS | Prevalence | Humans | Middle Aged | Risk Factors | Male | Neoplasms - prevention & control | Incidence | Young Adult | Overweight - epidemiology | Obesity - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Neoplasms - epidemiology | Scandinavian and Nordic Countries - epidemiology | Epidemiology | Biometry | Analysis | VDP | Klinisk medisinske fag: 750 | Onkologi: 762 | Oncology: 762 | Medisinske Fag: 700 | Clinical medical disciplines: 750 | Medical disciplines: 700
Journal Article